View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 13, 2021updated 18 Jan 2022 6:54pm

Sentiment about post-Brexit impact on the UK healthcare sector worsens since the onset of COVID-19: Poll

Brexit is believed to have serious implications for the healthcare sector of the UK, which is dependent on the European Union (EU) for workforce and pharmaceuticals supplies.

Brexit is believed to have serious implications for the healthcare sector of the UK, which is dependent on the European Union (EU) for workforce and pharmaceuticals supplies.

GlobalData has conducted a poll to assess whether the sentiment on the impact of Brexit on the UK healthcare sector post-Brexit changed since the COVID-19 crisis started.

Analysis of the results shows that the sentiment has turned more negative since the start of the COVID-19 crisis, as opined by a majority 45% of the respondents.

Post Brexit impact on the UK healthcare sector

Comparatively, the sentiment remained unchanged among 29% of the respondents, while it turned positive for 26% of the respondents.

The analysis is based on 302 responses received from the readers of Pharmaceutical Technology, a Verdict network site, between 01 September 2020 and 04 January 2021.

Impact of Brexit on the UK healthcare sector

After the UK voted to leave the EU in June 2016, much attention has been paid to the trade sector, although the impact of Brexit on the healthcare sector remains less discussed. The UK’s National Health Service (NHS) is one of the biggest employers in the country with a workforce of more than 1.5 million and an annual budget that exceeds £110bn ($123.5bn).

Under the new agreement signed in December 2020, there will be no free movement of labour between the UK and EU. The NHS and the social care sector may not be able to function in the same way without the international workforce, according to The King’s Fund, an independent charitable organisation.

Further, the NHS is expected to face severe shortage of workforce in the short term. The NHS is expected to need a minimum of 5,000 more nurses a year from overseas, while measures to expand domestic capacity is undertaken, adds The King’s Fund.

Brexit is also expected to put pressure on the UK’s medicines supply chain. The UK becoming the sole regulator of pharmaceuticals and medical devices could lead to delay in accessing new medicines, though no immediate impact is anticipated, according to GlobalData.

Related Companies

Free Report

Navigate your business through the ‘new normal’

COVID-19 continues to dominate headlines the world over. It has already affected our lives forever. The way we work, shop, eat, seek medical advice, and socialize will all be different in the future. Quite how different remains to be seen, but all industries must plan for multiple eventualities.  Faced with an explosion of conflicting information on how to plan and implement successful recovery strategies, decision-makers are in dire need of a single, reliable source of intelligence.   GlobalData’s COVID-19 Executive Briefing gives you access to unparalleled data and insights to successfully navigate the uncertain road to recovery across the world’s largest industries. Understand every aspect of this disruptive theme by delving into: 
  •  COVID-19 infection update, with statistics on the spread, testing by country, as well as the latest data on vaccines and therapeutic developments 
  • Economic impact overview, covering stock market indices, GDP, unemployment rates, policy responses & GlobalData’s economic recovery scorecards 
  • Sector developments, with access to sector insight summaries, cross-sector indices and the leaders and laggards in each industry vertical 
Whatever your company’s imminent strategic plans, the long-lasting impact of COVID-19 must not be overlooked. Find out how to futureproof your business operations – download our report today. 
by GlobalData
Enter your details here to receive your free Report.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy